CONOR CRONIN: Open Payments
NPI 1003444720 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 53 payments from 15 companies in 2025. Trend: 2023 $262 · 2024 $326 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 8 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $187 |
| ABBVIE INC. | 12 | $138 |
| Vanda Pharmaceuticals Inc. | 5 | $119 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Corium, LLC | 4 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Lundbeck LLC | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, FANAPT, Auvelity, REXULTI, Azstarys, COBENFY.
Industry payments across AL — which companies pay providers there.
